FMP
Royalty Pharma plc
RPRX
NASDAQ
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
25.84 USD
0.05 (0.193%)
2023
2022
2021
2020
2.35B
2.24B
2.29B
2.12B
560.66M
5.67M
23M
88.11M
1.79B
2.23B
2.27B
2.03B
862.4M
1.31B
858.75M
527M
52M
177.11M
200.08M
26M
249.75M
227.3M
182.83M
182M
0
0
0
0
249.75M
227.3M
182.83M
182M
0
909.91M
475.84M
319M
1.49B
977.5M
1.43B
1.59B
207.94M
-77M
-189.51M
106.56M
1.7B
230.06M
1.24B
1.7B
0
187.23M
762.45M
1.15B
1.13B
42.83M
478.75M
495.2M
3.41
0.1
1.15
1.32
2.53
0.1
1.15
1.32
447.6M
437.96M
414.79M
375.44M
602.9M
437.97M
414.8M
375.45M
1.89B
928.56M
1.45B
1.68B
All figures are in USD.